Deep-intronic ATM mutation detected by genomic resequencing and corrected in vitro by antisense morpholino oligonucleotide (AMO)
Page 1 of 1
Deep-intronic ATM mutation detected by genomic resequencing and corrected in vitro by antisense morpholino oligonucleotide (AMO)
Jon Moulton Wed Dec 05, 2012 2:45 pm
Cavalieri S, Pozzi E, Gatti R, Brusco Alfredo. Deep-intronic ATM mutation detected by genomic resequencing and corrected in vitro by antisense morpholino oligonucleotide (AMO). Eur J Hum Genet
. 2012;[Epub ahead of print] /10.1038/ejhg.2012.266
. 2012;[Epub ahead of print] /10.1038/ejhg.2012.266
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 62
Location : Philomath, Oregon, USA -
Similar topics» Megalencephalic leukoencephalopathy with subcortical cysts type 1 (MLC1) due to a homozygous deep intronic splicing mutation (c.895-226T>G) abrogated in vitro using an antisense morpholino oligonucleotide
» In vitro antisense therapeutics for a deep intronic mutation causing Neurofibromatosis type 2
» Antisense-based RNA therapy of factor V deficiency: in vitro and ex vivo rescue of a F5 deep-intronic splicing mutation
» Isoform Expression by Inhibition of Intronic Polyadenylation with Antisense Morpholino Oligonucleotides
» Optimization of Morpholino Antisense Oligonucleotides Targeting the Intronic Repressor Element1 in Spinal Muscular Atrophy
» In vitro antisense therapeutics for a deep intronic mutation causing Neurofibromatosis type 2
» Antisense-based RNA therapy of factor V deficiency: in vitro and ex vivo rescue of a F5 deep-intronic splicing mutation
» Isoform Expression by Inhibition of Intronic Polyadenylation with Antisense Morpholino Oligonucleotides
» Optimization of Morpholino Antisense Oligonucleotides Targeting the Intronic Repressor Element1 in Spinal Muscular Atrophy
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum